We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Aussie Industry Seeks Fast Track for New Cancer Drugs
Aussie Industry Seeks Fast Track for New Cancer Drugs
Australian drugmakers want the government to create fast-track approval pathways for new cancer drugs, as well as parallel review processes that simultaneously assess safety and efficacy and reimbursement eligibility for new drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor